Healthcare & Life Sciences Industry Updates

Google News – Clinical Trials External News

Qtis.ai Launches AI-Native Clinical Research Division, Enters Fast-Growing $7.4 Billion CTMS Market - Yahoo Finance

news.google.com · 11 Jul 2026

Google News – Clinical Trials External News

Qtis.ai Launches AI-Native Clinical Research Division, Enters Fast-Growing $7.4 Billion CTMS Market - Business Wire

news.google.com · 11 Jul 2026

Google News – Clinical Trials External News

Some GLP-1 Users Are Scaling Back Their Dose, Should You? - Katie Couric Media

news.google.com · 11 Jul 2026

Google News – Clinical Trials External News

Qtis.ai Launches AI-Native Clinical Research Platform, Wins First CTMS Customer - citybiz

news.google.com · 11 Jul 2026

Google News – Clinical Trials External News

Phase 1 clinical trials, explained: 11 things to know - UT MD Anderson

news.google.com · 11 Jul 2026

Google News – Clinical Trials External News

3 Psychedelic Stocks With Potential Clinical Trial Catalysts - Yahoo Finance

news.google.com · 11 Jul 2026

Google News – Clinical Trials External News

CLB: Explore Cutting-Edge Clinical Trials - Endocrine Society

news.google.com · 11 Jul 2026

Google News – Clinical Trials External News

Rethinking Alzheimer’s clinical trials to include atypical forms of the disease - Hospital Clínic Barcelona

news.google.com · 11 Jul 2026

Google News – Pharmaceuticals External News

Barclays cuts Ionis Pharmaceuticals stock price target on trial miss - Investing.com

news.google.com · 11 Jul 2026

Google News – Pharmaceuticals External News

Ionis Pharmaceuticals (IONS) Shares Drop After Roche Discontinues Trials - GuruFocus

news.google.com · 11 Jul 2026

Google News – Pharmaceuticals External News

Is Aurinia Pharmaceuticals (AUPH) Using Combination LN Trials to Redefine Its LUPKYNIS Strategy? - simplywall.st

news.google.com · 11 Jul 2026

Google News – Pharmaceuticals External News

Alnylam Pharmaceuticals (ALNY) Could Be 28% Undervalued Following Rival ATTR Trial Failure - simplywall.st

news.google.com · 11 Jul 2026

Google News – Pharmaceuticals External News

FDA clears Quoin Pharmaceuticals’ QRX003 IND for Phase II PSS trial - Clinical Trials Arena

news.google.com · 11 Jul 2026

Google News – Pharmaceuticals External News

Keeping pace with generative AI in pharmaceutical and healthcare organisations - Clinical Trials Arena

news.google.com · 11 Jul 2026

Google News – Biopharma External News

A $10B deal, China trial scrutiny and highlights from ADA 2026 - Fierce Pharma

news.google.com · 11 Jul 2026

News & Articles

Cancer Is Rarely Caused By One Mistake: Why Healthcare Professionals Must Improve Public Understanding

Beyond AI: Why Human Empathy Will Remain Healthcare's Most Valuable Skill

Why healthcare providers are sidelining employees amid coronavirus pandemic

For adults with prediabetes, lifestyle intervention lowered risk of developing multiple chronic conditions

New Alzheimer’s blood test may tell when symptoms are around the corner

4 takeaways from MDUFA VI draft agreement

J&J wins FDA approval for dual-energy ablation catheter

Physicians’ wearable data use hampered by reimbursement, workflow barriers: survey

Vacancy: National Consultant (NO C) to strengthen maternal and newborn health systems.

Stanford Health Care Tri-Valley launches hospital expansion - Stanford Medicine

HHSC, UT Southwestern Medical Center celebrate opening of new psychiatric hospital in Dallas - UT Southwestern Medical

Hospital and health system leaders participate in Healthcare of Tomorrow Conference - American Hospital Association

HCA Healthcare hospitals earn 26 Press Ganey Human Experience Awards for patient experience - HCA Healthcare Today

CEO Nancy Brown named to Becker’s Hospital Review’s 2026 “Great Leaders in Healthcare” list - www.heart.org

Enhancing healthcare workers’ safety and well-being through a comprehensive qualitative analysis across hospital settings - Nature

Providers race to scale hospital-at-home before reimbursement changes - Modern Healthcare

One or Two Health Systems Controlled the Entire Market for Inpatient Hospital Care in Nearly Half of Metropolitan Areas in 2024 - KFF

How the hospital-at-home program offers alternative care as demand surges - investigatetv.com

Layoffs, closures tracker: Adventist Health cuts 132 jobs - Modern Healthcare

Experts: Cuts to federal student loans could hurt first generation students, healthcare industry - MPR News

Qtis.ai Launches AI-Native Clinical Research Division, Enters Fast-Growing $7.4 Billion CTMS Market - Yahoo Finance

Qtis.ai Launches AI-Native Clinical Research Division, Enters Fast-Growing $7.4 Billion CTMS Market - Business Wire

Some GLP-1 Users Are Scaling Back Their Dose, Should You? - Katie Couric Media

Qtis.ai Launches AI-Native Clinical Research Platform, Wins First CTMS Customer - citybiz

Phase 1 clinical trials, explained: 11 things to know - UT MD Anderson

3 Psychedelic Stocks With Potential Clinical Trial Catalysts - Yahoo Finance

CLB: Explore Cutting-Edge Clinical Trials - Endocrine Society

Rethinking Alzheimer’s clinical trials to include atypical forms of the disease - Hospital Clínic Barcelona

Barclays cuts Ionis Pharmaceuticals stock price target on trial miss - Investing.com

Ionis Pharmaceuticals (IONS) Shares Drop After Roche Discontinues Trials - GuruFocus

Is Aurinia Pharmaceuticals (AUPH) Using Combination LN Trials to Redefine Its LUPKYNIS Strategy? - simplywall.st

Alnylam Pharmaceuticals (ALNY) Could Be 28% Undervalued Following Rival ATTR Trial Failure - simplywall.st

FDA clears Quoin Pharmaceuticals’ QRX003 IND for Phase II PSS trial - Clinical Trials Arena

Keeping pace with generative AI in pharmaceutical and healthcare organisations - Clinical Trials Arena

A $10B deal, China trial scrutiny and highlights from ADA 2026 - Fierce Pharma